
### [MONDO:0016106](http://purl.obolibrary.org/obo/MONDO_0016106)
**Label:** progressive muscular dystrophy

**Subclasses:** [MONDO:0016830](http://purl.obolibrary.org/obo/MONDO_0016830) (Emery-Dreifuss muscular dystrophy), [MONDO:0010680](http://purl.obolibrary.org/obo/MONDO_0010680) (X-linked Emery-Dreifuss muscular dystrophy), [MONDO:0016971](http://purl.obolibrary.org/obo/MONDO_0016971) (limb-girdle muscular dystrophy), [MONDO:0017099](http://purl.obolibrary.org/obo/MONDO_0017099) (facioscapulohumeral dystrophy), [MONDO:0015151](http://purl.obolibrary.org/obo/MONDO_0015151) (autosomal dominant limb-girdle muscular dystrophy), [MONDO:0015152](http://purl.obolibrary.org/obo/MONDO_0015152) (autosomal recessive limb-girdle muscular dystrophy), [MONDO:0008029](http://purl.obolibrary.org/obo/MONDO_0008029) (Bethlem myopathy), [MONDO:0020336](http://purl.obolibrary.org/obo/MONDO_0020336) (autosomal dominant Emery-Dreifuss muscular dystrophy), [MONDO:0008406](http://purl.obolibrary.org/obo/MONDO_0008406) (autosomal recessive Emery-Dreifuss muscular dystrophy), [MONDO:0007614](http://purl.obolibrary.org/obo/MONDO_0007614) (congenital fibrosis of extraocular muscles), [MONDO:0010401](http://purl.obolibrary.org/obo/MONDO_0010401) (X-linked myopathy with postural muscle atrophy), [MONDO:0010684](http://purl.obolibrary.org/obo/MONDO_0010684) (X-linked myopathy with excessive autophagy), [MONDO:0010311](http://purl.obolibrary.org/obo/MONDO_0010311) (Becker muscular dystrophy), [MONDO:0016107](http://purl.obolibrary.org/obo/MONDO_0016107) (myotonic dystrophy), [MONDO:0016899](http://purl.obolibrary.org/obo/MONDO_0016899) (Duchenne and Becker muscular dystrophy), [MONDO:0018549](http://purl.obolibrary.org/obo/MONDO_0018549) (late-onset scapuloperoneal muscular dystrophy with hyaline bodies), 

**Corr. equiv. classes:** [Orphanet:102015](http://www.orpha.net/ORDO/Orphanet_102015), [Orphanet:102014](http://www.orpha.net/ORDO/Orphanet_102014), [Orphanet:25980](http://www.orpha.net/ORDO/Orphanet_25980), [OMIM:300376](http://purl.obolibrary.org/obo/OMIM_300376), [Orphanet:261](http://www.orpha.net/ORDO/Orphanet_261), [Orphanet:263](http://www.orpha.net/ORDO/Orphanet_263), [OMIM:181350](http://purl.obolibrary.org/obo/OMIM_181350), [Orphanet:262](http://www.orpha.net/ORDO/Orphanet_262), [OMIM:135700](http://purl.obolibrary.org/obo/OMIM_135700), [OMIM:300696](http://purl.obolibrary.org/obo/OMIM_300696), [Orphanet:178461](http://www.orpha.net/ORDO/Orphanet_178461), [Orphanet:431263](http://www.orpha.net/ORDO/Orphanet_431263), [OMIM:158810](http://purl.obolibrary.org/obo/OMIM_158810), [OMIM:310440](http://purl.obolibrary.org/obo/OMIM_310440), [Orphanet:45358](http://www.orpha.net/ORDO/Orphanet_45358), [Orphanet:98855](http://www.orpha.net/ORDO/Orphanet_98855), [OMIM:310300](http://purl.obolibrary.org/obo/OMIM_310300), [Orphanet:269](http://www.orpha.net/ORDO/Orphanet_269), [Orphanet:610](http://www.orpha.net/ORDO/Orphanet_610), [Orphanet:98895](http://www.orpha.net/ORDO/Orphanet_98895), [Orphanet:206647](http://www.orpha.net/ORDO/Orphanet_206647), [Orphanet:98863](http://www.orpha.net/ORDO/Orphanet_98863), [Orphanet:98853](http://www.orpha.net/ORDO/Orphanet_98853), 

**Class expressions from DL-Learner:**

- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 51.77%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) 51.77%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 51.77%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) 51.77%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 51.77%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) 51.77%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) 50.57%
- [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 48.40%
- [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) 48.40%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0009121](http://purl.obolibrary.org/obo/HP_0009121) (Abnormal axial skeleton morphology) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 48.40%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0009121](http://purl.obolibrary.org/obo/HP_0009121) (Abnormal axial skeleton morphology) and [HP:0011021](http://purl.obolibrary.org/obo/HP_0011021) (Abnormality of circulating enzyme level) 48.40%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0009121](http://purl.obolibrary.org/obo/HP_0009121) (Abnormal axial skeleton morphology) 48.40%
- [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) 48.25%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 47.01%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) 47.01%


